Chuck Papageorgiou | Source | CEO at NeuroEM Therapeutics

Stay on top of emerging IT trends in biomedicine. Read the latest news on genomics, computational science, and more. Get recent updates today!

Chuck Papageorgiou writes: "With no effective prevention or long-term treatment, receiving a diagnosis of Alzheimer’s disease can seem like a fate worse than death for patients and their families and caregivers. However, a wave of innovation is bringing new hope to the 7 million Americans already living with Alzheimer's disease and the 500,000 who will receive this devastating diagnosis each year."